Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Viemed HealthcareVMD -2.91%89 Earnings Yield (Joel Greenblatt) % is 5.35% as of Jun. 2026, which is 1% above its 10-year median of 5.32. GuruFocus rates VMD with a GF Score™ of 89/100 and a GF Value™ of $10.95 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 848 Medical Devices & Instruments companies, Viemed Healthcare ranks better than 78.66% on this metric.
Viemed Healthcare's Enterprise Value for the quarter that ended in Jun. 2026 was $437.1 Mil.
Viemed Healthcare's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was $23.4 Mil. Viemed Healthcare's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2026 was 5.35%.
The historical rank and industry rank for Viemed Healthcare's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
VMD'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 1.78 Med: 5.32 Max: 12.43
Current: 6.39
During the past 10 years, the highest Earnings Yield (Joel Greenblatt) of Viemed Healthcare was 12.43%. The lowest was 1.78%. And the median was 5.32%.
VMD's Earnings Yield (Joel Greenblatt) % is ranked better than 78.66% of 848
companies
in the Medical Devices & Instruments industry
Industry Median: 0.82
vs VMD: 6.39
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Viemed Healthcare's Forward Rate of Return (Yacktman) % for the quarter that ended in Jun. 2026 was 21.91%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Viemed Healthcare Earnings Yield (Joel Greenblatt) % Related Terms
Viemed Healthcare Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Viemed Healthcare's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Viemed Healthcare's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viemed Healthcare Earnings Yield (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Viemed Healthcare's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Viemed Healthcare's Earnings Yield (Joel Greenblatt) % falls into.
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Viemed Healthcares Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
Viemed Healthcare's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $23.4 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 5.35% mean?
Viemed Healthcare (VMD) has a Earnings Yield (Joel Greenblatt) % of 5.35% as of Jun. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Viemed Healthcare and its competitors. This is near median its historical median of 5.32. Over the past decade, Viemed Healthcare's Earnings Yield (Joel Greenblatt) % has ranged from 1.78 to 12.43. According to the industry distribution chart, Viemed Healthcare ranks #181 out of 848 companies in the Medical Devices & Instruments industry, placing it in the top 21.3%.
Is Viemed Healthcare's Earnings Yield (Joel Greenblatt) % too high?
Viemed Healthcare's current Earnings Yield (Joel Greenblatt) % of 5.35% is near median its 10-year median of 5.32. Over the past 10 years, this metric has ranged from a low of 1.78 to a high of 12.43. The Medical Devices & Instruments industry median Earnings Yield (Joel Greenblatt) % is 0.82. Viemed Healthcare's value of 5.35% is 552.4% above this industry median. Based on the distribution chart, Viemed Healthcare ranks #181 out of 848 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Viemed Healthcare has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Viemed Healthcare's Earnings Yield (Joel Greenblatt) % compare to OFIX and VREX?
According to the Medical Devices & Instruments industry distribution chart, Viemed Healthcare ranks #181 out of 848 companies for Earnings Yield (Joel Greenblatt) %. This places Viemed Healthcare in the top 21% of its industry — outperforming the majority of peers. The industry median Earnings Yield (Joel Greenblatt) % is 0.82. Viemed Healthcare's value of 5.35% is 552.4% above this benchmark. Historically, Viemed Healthcare's own Earnings Yield (Joel Greenblatt) % has ranged from 1.78 to 12.43 over the past decade. While the company's 10-year median is 5.32 vs. the industry median of 0.82, Viemed Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median Earnings Yield (Joel Greenblatt) % among Medical Devices & Instruments companies is 0.82, based on 848 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Viemed Healthcare's current Earnings Yield (Joel Greenblatt) % of 5.35% is 552.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Viemed Healthcare and its competitors. For the Medical Devices & Instruments industry, the median Earnings Yield (Joel Greenblatt) % is 0.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viemed Healthcare's current Earnings Yield (Joel Greenblatt) % is 5.35%, which is near median its own 10-year median of 5.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viemed Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Viemed Healthcare (VMD) is currently considered Modestly Undervalued. The stock's GF Value™ is $10.95, compared to a current price of $9.52 — trading 13.1% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 5.35%, which is near median its 10-year median of 5.32 and 552.4% above the Medical Devices & Instruments industry median of 0.82. Viemed Healthcare's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Viemed Healthcare (VMD), the current Earnings Yield (Joel Greenblatt) % is 5.35% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Viemed Healthcare (VMD) Overvalued in 2026?
Based on GuruFocus' analysis, Viemed Healthcare stock appears to be undervalued.
The current stock price of $9.52 is trading 13.1% below its estimated GF Value™ of $10.95.
GuruFocus considers Viemed Healthcare to be Modestly Undervalued.
Key valuation signals for VMD:
Earnings Yield (Joel Greenblatt) %: 5.35% (near median its 10-year median of 5.32)
GF Value™: $10.95 vs. price of $9.52 (13.1% below fair value)
Industry Position: 552.4% above the Medical Devices & Instruments median (#181 of 848)
No single metric tells the full story. See the VMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.
89GF Score
Get the complete analysis for VMD
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VMD has been successfully added to your 
